EPISODE · May 30, 2024 · 17 MIN
Ep.3 What We're Watching at ASCO 2024
from Biotech Matters · host Bluestar BioAdvisors
As the Bluestar team prepares to head to ASCO 2024 this upcoming weekend, Bluestar Principal Jeff Fineberg sits down with Bluestar Managing Director Erin Olsen to talk about interesting abstracts related to two topics: What are the unmet needs in 1L therapy? The KRAS G12C mutation landscape
NOW PLAYING
Ep.3 What We're Watching at ASCO 2024
No transcript for this episode yet
Similar Episodes
May 25, 2026 ·39m
May 17, 2026 ·37m
May 9, 2026 ·24m
May 8, 2026 ·39m
May 7, 2026 ·56m
Apr 30, 2026 ·21m